Adverse drug reactions costs

Thirteen years ago, the journal of the American Medical Association (JAMA 1996) reported that 108, 000 Americans died in hospital from adverse drug reactions and 2,2 million Americans had reactions to FDA approved medications, In the UK an estimated 1,6 million bed days are due to in-patient adverse drug reactions and up to 6,5% of new patient admissions may be related to an adverse drug reaction. Recent estimates suggest that adverse drug reactions cost the NHS in England in excess of 637 million annually,... 

O Allergic and pseudoallergic reactions represent 23.8% of reported adverse drug reactions, cause considerable morbidity and mortality, and are costly. 

Chlorpromazine, prochlorperazine, promethazine, methylprednisolone, lorazepam, metoclopramide, dexamethasone, or dronabinol may be used for adult patients. Around the clock dosing should be considered. The choice of specific agent should based on patient specific factors, including potential for adverse drug reactions, and cost. SSRIs are effective for breakthrough nausea and vomiting but they are not superior to the less expensive antiemetics above. 

Adverse drug reactions (ADRs) cost approximately one hundred and thirty nine billion dollars annually 2—4 in the United States. This number is larger than the... 

How common are these problems Forty years ago a study showed that 18 to 30 percent of all hospitalised patients have a drug reaction, and the duration of their hospitalisation is about doubled as a consequence/ Despite awareness, this has changed little—the recent publication To Err is Human (2000) by the Institute of Medicine in the US quoted a 2% incidence of preventable adverse drug reactions in hospitaiised patients, with—apart from the human cost—a financial implication of 2000 miiiion per year in that country. 

In 1986, nearly two decades after NMS had become an identifiable syndrome, the FDA at last began to force the drug companies to add the adverse drug reaction to their neuroleptic labels. Since the disease is fatal in approximately 20% of cases when it goes unrecognized and untreated, the failure to properly inform physicians cost many lives and untold suffering. 

Cl5me KE, German MR. Adverse drug reaction reporting. Focus on cost and prevention. Pharm and Ther 1992 17 1145-56. 

Ernst (2) projected that costs of 177 billion a year are attributable to medication misuse. Adverse drug events (ADEs) are instances when patient harm results from the use of medication. This includes both adverse drug reactions/ which were discussed in Chapter 25/... 

Continue therapy until apparent cure has been achieved most acute infections are treated for 5-10 days. There are many exceptions to this, such as typhoid fever, tuberculosis and infective endocarditis, in which relapse is possible long after apparent clinical cure and so the drugs are continued for a longer time, determined by comparative or observational trials. Otherwise, prolonged therapy is to be avoided because it increases costs and the risks of adverse drug reactions. 

Outcomes, or consequences, of the services described were considered in all 104 papers. Nineteen (18%) of the papers were found to be full economic analyses because they considered two or more alternatives to care and measured both input costs and outcomes. The most common outcomes measured were drug costs avoided, length of hospital stay, use of nonpharmaceutical resources, rates of adverse drug reactions, frequency of pharmacist-driven therapeutic interventions, and qualitative changes in prescribing patterns. In 93 (89%) of the papers, beneficial financial impacts of clinical pharmacy services were described. 

---